Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| RTI Health Solutions | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study will be an observational, cross-sectional study of knowledge, understanding, and self-reported behavior among a sample of physicians with recent experience in prescribing Diane-35 or its generics in a total of five European countries. The primary objective of this study is to measure physician knowledge and understanding of the key information contained in the Diane-35 educational material: Patient information card, and Prescribers' Checklist.
Specifically, the following objectives will be addressed:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cyproterone acetate 2mg/ethinylestradiol 35 μg (Diane-35) | Prescribers of Diane-35 who agree and fulfill the criteria inclusion to participate in the survey |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cyproterone acetate 2mg/ethinylestradiol 35 μg (Diane-35) | Drug | Cyproterone acetate 2mg/ethinylestradiol 35 μg |
|
| Measure | Description | Time Frame |
|---|---|---|
| The knowledge of the physician concerning Diane-35 | The knowledge will be assessed based on a questionnaire with 22 questions which wil assess physician knowledge on key information contained in the Diane-35 educational material including patient information card, prescribers' checklist | Day1 |
Not provided
Not provided
Inclusion Criteria:
-Physicians eligible to participate will have recently prescribed (e.g., within previous 6 months) Diane-35 or its generics
Not provided
Not provided
Not provided
Physicians eligible to participate who have recently prescribed (e.g., within previous 6 months) Diane-35 or its generics
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bayer Study Director | Bayer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Many Locations | Austria | |||||
Not provided
| ID | Term |
|---|---|
| D000152 | Acne Vulgaris |
| ID | Term |
|---|---|
| D017486 | Acneiform Eruptions |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D012625 | Sebaceous Gland Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D017373 | Cyproterone Acetate |
| D004997 | Ethinyl Estradiol |
| C032640 | Cyproterone acetate, ethinyl estradiol drug combination |
| ID | Term |
|---|---|
| D003534 | Cyproterone |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
| D000072473 |
Not provided
Not provided
Not provided
Not provided
Not provided
| Many Locations |
| Czechia |
| Many Locations | France |
| Many Locations | Netherlands |
| Many Locations | Spain |
| Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D013258 | Steroids, Chlorinated |
| D009651 | Norpregnatrienes |
| D009650 | Norpregnanes |
| D009654 | Norsteroids |
| D042782 | Estrogenic Steroids, Alkylated |
| D045166 | Estradiol Congeners |
| D012739 | Gonadal Steroid Hormones |
| D042341 | Gonadal Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |